Lilly says its experimental drug retatrutide met the primary endpoint and key secondary endpoints in a new study.

One pill for obesity is already on the market, and more are on the way. But the injected drugs have key advantages.

A new weekly injection may soon transform how millions manage Parkinson’s disease. For over 8.5 million people living with this condition worldwide, daily treatment has meant taking levodopa and ...

This reflects the confidence pharmaceutical innovators place in Pyramid’s expanded state-of-the-art facility to deliver ...

Bags of IV drugs distributed nationwide are being recalled for being mislabeled as a lesser-dose than what the drugs actually are, increasing the risk for overdosing and even death, according to the ...

Mark Cuban’s latest move to disrupt the pharmaceutical supply chain is expanding — this time, tackling the injectable drug market through a new partnership with distributor Morris & Dickson. His ...